Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Regeneus Ltd. ( (AU:CMB) ) has provided an update.
Cambium Bio Limited, a company involved in the biotechnology sector, has announced a change in its substantial holding status. The company ceased to be a substantial holder due to the expiration of voluntary escrow arrangements related to its merger with Cambium Medical Technologies, LLC. This change affects over 2.4 million ordinary shares, potentially impacting the company’s control over voting interests.
More about Regeneus Ltd.
YTD Price Performance: -30.0%
Average Trading Volume: 20,744
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$5.12M
For an in-depth examination of CMB stock, go to TipRanks’ Stock Analysis page.